HemaSphere (Jun 2022)
P764: RESPONSE AND SURVIVAL OUTCOMES WITH HYPOMETHYLATING AGENTS IN AN ARGENTINEAN COHORT OF 113 PATIENTS WITH CHRONIC MYELOMONOCITIC LEUKEMIA
- J. Gonzalez,
- A. Perusini,
- F. Russo,
- L. Fuentes,
- T. Deluca,
- A. L. Basquiera,
- A. Navickas,
- L. Kornblihtt,
- N. Pintos,
- E. Nucifora,
- M. Iastrebner,
- A. Enrico,
- J. Arbelbide,
- C. Belli
Affiliations
- J. Gonzalez
- 1 Hematology, Hospital Agudos Carlos G Durand
- A. Perusini
- 2 Hematology, Hospital Italiano de Buenos Aires
- F. Russo
- 3 Hematology, Hospital Paroissien
- L. Fuentes
- 4 Hematology, Instituto Alexander Femming, CABA
- T. Deluca
- 5 Hematology, Hospital Italiano de La Plata, La Plata
- A. L. Basquiera
- 6 Hematology, Hospital Privado de Cordoba, Cordoba
- A. Navickas
- 7 Hematology, Hospital El Cruce, Florencio Varela
- L. Kornblihtt
- 8 Hematology, Hospital de Clinicas Jose de San Martin
- N. Pintos
- 9 Hematology, Sanatorio Mendez
- E. Nucifora
- 2 Hematology, Hospital Italiano de Buenos Aires
- M. Iastrebner
- 10 Hematology, Sanatorio Sagrado Corazon
- A. Enrico
- 5 Hematology, Hospital Italiano de La Plata, La Plata
- J. Arbelbide
- 2 Hematology, Hospital Italiano de Buenos Aires
- C. Belli
- 11 Genetic, IMEX-CONICET/ANM, CABA, Argentina
- DOI
- https://doi.org/10.1097/01.HS9.0000845940.81565.29
- Journal volume & issue
-
Vol. 6
pp. 659 – 660
Abstract
No abstracts available.